Literature DB >> 8252600

Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart.

A F Doubell1, C Lazure, C Charbonneau, G Thibault.   

Abstract

OBJECTIVE: The heart contains proteins of the annexin family, a unique group of calcium binding proteins. This study was aimed at identifying the major cardiac annexins and determining their distribution in the rat heart.
METHODS: Annexins were isolated by affinity chromatography and purified by ion exchange high pressure liquid chromatography. Identification of isolated proteins by immunoblotting was confirmed by partial amino acid sequence determination. Antisera raised against the isolated proteins were used for immunohistochemistry by the avidin-biotin-peroxidase technique.
RESULTS: Two annexins were isolated and purified. Amino acid sequencing confirmed their identities as annexin V and VI. Immunohistochemistry showed that both annexins were present in cardiac myocytes and non-myocytes, but a distinct pattern of distribution was seen for each annexin. Annexin V immunoreactivity was enhanced in the atria compared with the ventricles, whereas annexin VI was more uniformly distributed. In individual cardiac myocytes annexin V was distributed throughout the cell by contrast with annexin VI, which localised to the sarcolemma. Intercalated discs displayed immunoreactivity for both annexins, most prominently for annexin VI. The most striking immunoreactivity for annexin V occurred in vascular endothelial cells, both in the microcirculation and in the major coronary vessels. Immunoreactivity for annexin VI in vascular structures was localised to the nuclei of endothelial and smooth muscle cells.
CONCLUSIONS: Annexins V and VI are the major cardiac annexins. The localisation of these annexins to different components of cardiac myocytes will serve to direct the search for their functions in the heart. The striking immunoreactivity for annexins, particularly annexin V, in the coronary vessels indicates that the functions of cardiac annexins include a role in the coronary circulatory system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252600     DOI: 10.1093/cvr/27.7.1359

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Immunological development and cardiovascular function are normal in annexin VI null mutant mice.

Authors:  T E Hawkins; J Roes; D Rees; J Monkhouse; S E Moss
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy.

Authors:  S W Jans; Y F de Jong; C P Reutelingsperger; G J van der Vusse; M van Bilsen
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

3.  Purification of cardiac annexin V from the beagle dog heart and changes in its localization in the ischemic rat heart.

Authors:  N Kaneko; R Matsuda; F Chiwaki; S Hosoda
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

4.  DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis.

Authors:  Timothy E Hawkins; Debipriya Das; Barry Young; Stephen E Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

5.  Interaction of annexin A6 with alpha actinin in cardiomyocytes.

Authors:  Sumita Mishra; Vivek Chander; Priyam Banerjee; Jae G Oh; Ekaterina Lifirsu; Woo J Park; Do H Kim; Arun Bandyopadhyay
Journal:  BMC Cell Biol       Date:  2011-01-28       Impact factor: 4.241

6.  Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy.

Authors:  Fan Qiu; Minjin Hu; Bo Tang; Xiufeng Liu; Hongqin Zhuang; Jie Yang; Zi-Chun Hua
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

7.  A conserved annexin A6-mediated membrane repair mechanism in muscle, heart, and nerve.

Authors:  Alexis R Demonbreun; Elena Bogdanovic; Lauren A Vaught; Nina L Reiser; Katherine S Fallon; Ashlee M Long; Claire C Oosterbaan; Michele Hadhazy; Patrick Gt Page; Prem Raj B Joseph; Gabrielle Cowen; Alexander M Telenson; Ammaarah Khatri; Katherine R Sadleir; Robert Vassar; Elizabeth M McNally
Journal:  JCI Insight       Date:  2022-07-22

8.  Cardiomyocyte damage control in heart failure and the role of the sarcolemma.

Authors:  Ashraf Kitmitto; Florence Baudoin; Elizabeth J Cartwright
Journal:  J Muscle Res Cell Motil       Date:  2019-09-13       Impact factor: 2.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.